GMV g medical innovations holdings limited

CEO Dr Yacov Geva has purchased 3,239,000 share on market since...

  1. 2,081 Posts.
    lightbulb Created with Sketch.  44
    CEO Dr Yacov Geva has purchased 3,239,000 share on market since December. As the company approaches it's CFDA approval which has Green Channel, whilst already receiving FDA, CE Mark, and TGA clearance for it's Prizma product, things are certainly heating up. The China factory is within weeks of completion, and MOU's total over $1Billion of sales in 5 years.

    Here is a summary of Dr Yacov Geva's purchases ON MARKET since December:

    18/12 - 733,000 ($262,791) on market

    06/02 - 720,000 ($209,031) on market

    07/02 - 750,000 ($229,741) on market

    03/04 - 500,000 ($139,069) on market

    03/04 - 536,000 ($144,806) on market


    Total - 3,239,000 shares on market and paid a total of $985,438

    Very bullish on this one, as is he (obviously). DYOR and AIMO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.